[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:breast-neoplasm":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":27,"states":28},"Breast Neoplasm",3,[7,15,21],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04641247","A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline\u002FTESARO-sponsored Niraparib Study",[11],"Phase 2","RECRUITING","2026-08-26T02:15:57.572488Z","2026-05-05T02:43:27.111224Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT06058650","Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities",[],"2026-08-26T02:15:31.806698Z","2026-05-05T02:43:27.093363Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT04692818","3D Ultrasound Breast Imaging",[],"2026-08-26T02:18:34.622081Z","2026-05-05T02:43:29.711318Z",[],[]]